enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Charity calls for change to prostate cancer testing guidelines

   www.aol.com/charity-calls-change-prostate-cancer...

   “Prostate Cancer UK’s new report makes it clear that this reluctance from my doctors was unfounded and outdated; prostate cancer diagnosis is safer and more effective now than it has ever been.

3. United States Preventive Services Task Force - Wikipedia

   en.wikipedia.org/wiki/United_States_Preventive...

   In the current recommendation published in 2018, the Task Force recommended that prostate-specific antigen (PSA)-based screening for prostate cancer screenings be an individual decision for men between the ages of 55 and 69. [18] In 2018 the Task Force gave PCa screening a C recommendation. [18]

4. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1] [2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.

5. What you should know to reduce the risk of prostate cancer - AOL

   www.aol.com/prostate-cancer-urologist-explains...

   More prostate cancer testing and detection for Black men. Recent research and guidelines from the Prostate Cancer Foundation highlight a significant update in prostate cancer screening for Black ...

6. Prostate cancer shouldn’t be a death sentence. But for a ...

   www.aol.com/finance/prostate-cancer-shouldn-t...

   The 2012 recommendation—or reverse recommendation, of sorts—“created confusion in the minds of men, but also primary care providers,” Knudsen says. ... And prostate cancer screening is ...

7. Active surveillance of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Active_surveillance_of...

   In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...